Several factors are associated with increased mortality in patients with bullous pemphigoid, with mortality rates increasing 5 years after diagnosis.

Recent studies highlight the potential pathophysiology and presentation of immune checkpoint inhibitor–associated cutaneous ...

Ingleton recommends that people who think they may have bullous pemphigoid go to a dermatologist to confirm the diagnosis and get help. “Get early treatment and understand that bullous ...

Bullous pemphigoid (BP), which has no FDA-approved ... is the first biologic drug to show an improvement in remission and symptoms in BP, and the first to allow patients to reduce the use of ...

Why? Bullous pemphigoid, with a similar pathogenesis, is associated with some neurologic diseases. Reviewed by Aaron Miller, MD, Professor of Neurology, Icahn School of Medicine at Mount Sinai and ...

First up is the ADEPT study in bullous pemphigoid (BP), a rare skin condition ... with no relapse, and standard treatment with oral corticosteroids had been tailed off without the need for any ...

“People with bullous pemphigoid live with unrelenting itch, blisters and painful lesions that can be debilitating and make it difficult to function daily. Moreover, current treatment options can ...